Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Daily News

Polypills Added to List of WHO’s Essential Medicines

Michael O'Riordan

August 02, 2023

News Daily News

With Focus on Stroke, Low-Dose Aspirin Still No Good for Primary Prevention

Todd Neale

July 26, 2023

News Daily News

Low-Dose Polypills Top Other Approaches for Initial BP Control: Meta-analysis

Todd Neale

April 26, 2023

News Conference News AHA 2022

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

Caitlin E. Cox

November 08, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

November 2025 Dispatch for the CV Team

What’s Going to Be Hot at AHA 2025?

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

CVD Still the Leading Cause of Death and Disease Globally

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

TCTMD’s Top 10 Most Popular Stories for June 2025

FDA Approves Triple Therapy Polypill for High Blood Pressure

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Use of Secondary CVD Prevention Meds Still Meager Worldwide

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

Polypills Added to List of WHO’s Essential Medicines

With Focus on Stroke, Low-Dose Aspirin Still No Good for Primary Prevention

Low-Dose Polypills Top Other Approaches for Initial BP Control: Meta-analysis

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

Polypill Bests Usual Care in Patients With Recent MI: SECURE

What’s Going to Be Hot at ESC 2022?

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content